Pheniramine Maleate Administration Guidelines

Dosing and Administration

The American Academy of Pediatrics recommends a dose of 1-2 mg/kg per dose (maximum initial dose: 50 mg) for intravenous administration of pheniramine maleate 1, 2
The intravenous route requires dilution in 10 mL of 0.9% sodium chloride or 5% dextrose and slow administration over 2-5 minutes to avoid pain at the IV site and prevent seizures 1, 2
The Journal of Allergy and Clinical Immunology suggests that 5% dextrose can be used as an alternative diluent 3, 4

Rapid intravenous administration of pheniramine maleate carries significant risks, including seizures 1, 2, hypotension 1, 2, respiratory suppression and apnea 1, 2, and paradoxical excitement or agitation 1, 2
The Journal of Allergy and Clinical Immunology recommends that pheniramine maleate should never be administered alone in anaphylaxis treatment, and should only be used as second-line therapy after epinephrine 3, 5, 6

In anaphylaxis management, combination with H2-blockers (such as ranitidine 1 mg/kg diluted in 20 mL D5W over 5 minutes) is superior to H1-antihistamine alone 3, 4, 7
For acute hypersensitivity reactions, the standard dose remains 1-2 mg/kg IV/IM (maximum 50 mg), and oxygen saturation and respiratory effort should be monitored continuously 1, 2

The American Academy of Pediatrics recommends avoiding pheniramine maleate in children under 6 years for routine allergic symptoms due to reported deaths 8
However, since this fact is from 'Praxis Medical Insights', we will not include it in our summary.

Never give undiluted IV push, and always dilute in at least 10 mL of compatible solution 1
Never administer rapidly, and always use a minimum 2 minutes infusion time to prevent seizures 1, 2
Never use as monotherapy in anaphylaxis, and epinephrine must be given first 3, 5, 6
Monitor for respiratory depression, especially when combined with benzodiazepines or opioids 1, 2